top of page
CA India Logo.png

PGT & ASSOCIATES

Chartered Accountant Firm

ESOPs Cost Your Company No Cash. Is the Discount Still Deductible?

Nov 3
9 min read

An employee buys a share worth ₹650 for ₹100. The company that issued it never writes a cheque, yet its accounts show a large employee cost.

Assessing Officers have long called that cost "notional" and added it back. The courts have mostly disagreed, but the deduction has to be timed and measured their way, not the accountant's way.

Quick answer: The discount on ESOPs, the market price less the exercise price, is deductible employee cost under section 37(1) of the Income-tax Act, 1961, now section 34(1) of the Income-tax Act, 2025. Claim it over vesting, true it up at exercise and reverse it for lapsed options.

ESOP expense deduction for employer companies under section 37(1), now section 34(1) of the Income-tax Act 2025

Contents

Is an ESOP discount an expense at all?

Under an ESOP the company promises shares at a fixed price in exchange for continued service. When it allots a share worth ₹650 for ₹100, it gives up ₹550 of value it could have raised from an outside investor.

That is the core of the argument for the employer: the discount is part of the salary bill, paid in shares instead of cash. The Revenue's usual objections are:

  • No money leaves the company, so nothing is "expended"

  • The liability is contingent until employees exercise

  • Issuing shares is a capital transaction, not a business expense

  • Circular No. 9 of 2007 allows a deduction only where shares are bought from a third party

What have the courts held?

Every High Court that has examined the question has allowed the deduction:

  • Biocon Ltd. (ITAT Bangalore, Special Bench, 2013): the discount is employee cost, deductible over the vesting period, adjusted at exercise and reversed for lapsing options. Reported at (2013) 35 taxmann.com 335.

  • CIT v. PVP Ventures Ltd. (Madras HC, 19 June 2012): the cost of ESOPs debited to the profit and loss account is allowable.

  • CIT v. Lemon Tree Hotels Ltd. (Delhi HC, 18 August 2015) and PCIT v. Lemon Tree Hotels (P.) Ltd. (Delhi HC, 2019): rejected the argument that only shares bought from a third party qualify, as it ignores how companies actually operate.

  • CIT v. Biocon Ltd. (Karnataka HC, 11 November 2020, ITA 653/2013): section 37(1) does not need a cash pay-out; "expenditure" includes a loss; the vested discount is an ascertained liability, not a contingent one. Reported at (2021) 430 ITR 151.

Tribunals now follow this line routinely, including in Kotak Mahindra Bank (Mumbai ITAT, 2017) and in TSI Yatra (Delhi ITAT, 2026), which held that a pending appeal in the Supreme Court did not dilute the binding High Court ruling.

One open point: the Revenue's appeal against the 2019 Delhi ruling was admitted by the Supreme Court. A June 2026 report says it has since been dismissed, but we could not verify the order, so treat the High Court rulings as the authority for now.

How is the deduction timed and measured?

The Special Bench in Biocon set out the mechanics that most assessments now follow:

  1. At grant: compute the discount per option as the market price on the grant date less the exercise price. No deduction yet.

  2. During vesting: deduct the discount on the options that vest in each year. With 25% vesting a year, a quarter of the discount goes into each year.

  3. At exercise: recompute the discount using the market price on the exercise date. Claim the extra amount, or reverse the excess if the price has fallen.

  4. On lapse: if options do not vest, or vest but are never exercised, the discount already claimed on them is offered as income in that year.

ESOP expense deduction timeline for the employer: grant, vesting, exercise true-up and lapse reversal

For an unlisted company, the exercise-date value usually comes from the merchant banker valuation already used for the employees' perquisite under Rule 3(8) of the 1962 Rules (Rule 15(6) of the 2026 Rules). The ESOP share valuation guide explains how that report works.

Worked example: 10,000 options from grant to exercise

The figures are illustrative.

Facts. An unlisted company grants 10,000 options on 1 April 2022 at an exercise price of ₹100. The merchant banker's value at grant is ₹400. A quarter of the options vest at the end of each year from FY 2022-23 to FY 2025-26.

  • Discount at grant: (₹400 − ₹100) × 10,000 = ₹30,00,000

  • Deduction in each vesting year: ₹300 × 2,500 = ₹7,50,000

  • In tax year 2026-27, employees exercise 9,000 options when the value is ₹650, and 1,000 vested options lapse unexercised

  • True-up on exercise: (₹650 − ₹400) × 9,000 = ₹22,50,000 additional deduction

  • Reversal on lapse: ₹300 × 1,000 = ₹3,00,000 offered as income

  • Net deduction over the life of the grant: ₹30,00,000 + ₹22,50,000 − ₹3,00,000 = ₹49,50,000

That ₹49,50,000 equals (₹650 − ₹100) × 9,000, which is also the perquisite taxed in the employees' hands. At the 25.168% rate for a company in the section 115BAA regime (section 200 of the 2025 Act), the deduction is worth about ₹12.46 lakh in tax.

Worked example of ESOP discount deduction: vesting claims, exercise true-up and lapse reversal for 10,000 options

Practice guide for professionals

For working papers across tax audit, GST and audit documentation, the ₹699 bundle of all four practice guides (₹299 each) is the closest match to this topic.

Why the books and the tax computation differ

Companies following Ind AS 102 charge the grant-date fair value of the options, worked out with an option-pricing model, over the vesting period. That number rarely equals the discount the courts used.

Point

Ind AS 102 books

Tax computation (Biocon approach)

Measure

Fair value of the option at grant

Market price less exercise price

Later price movement

Ignored for equity-settled plans

Trued up at exercise

Vested options that lapse

Charge not reversed through profit or loss

Reversed and taxed as income

Options forfeited before vesting

Charge reversed (true-up for expected vesting)

Not deducted, or reversed

The practical answer is a reconciliation schedule in the tax computation: book charge added back, Biocon-basis deduction claimed, with option-level working kept on file. The Special Bench itself said accounting principles cannot decide the computation of total income.

RSUs recharged by a foreign parent

Indian subsidiaries of foreign groups often grant RSUs of the parent's shares and pay the parent a recharge when the shares are delivered. Here there is real cash paid, so the debate is narrower.

  • The Mumbai Tribunal has repeatedly allowed such payments as employee cost in the cases of Goldman Sachs (India) Securities Pvt. Ltd.

  • Keep the recharge agreement, the parent's invoices and the employee-wise delivery data

  • The recharge is an international transaction: price it at arm's length and report it in the accountant's report, Form 3CEB under section 92E (section 172 of the 2025 Act). See the Form 3CEB guide.

  • If the parent bears the cost and charges nothing, the Indian company has nothing of its own to deduct

Start-ups and the TDS deferral

An eligible start-up (section 80-IAC, now section 140 of the 2025 Act) can defer the TDS on its employees' ESOP perquisite under section 192(1C), now section 392(3). The tax falls due within 14 days of the earliest of 48 months from the end of the relevant assessment year under the 1961 Act (60 months from the end of the tax year under section 289(3) of the 2025 Act), sale of the shares, or leaving the company.

That deferral is about the employee's tax and the employer's withholding. It does not move the company's own deduction, which still follows vesting and exercise. The employee side is covered in ESOP and RSU tax in India.

Decision checklist

  • Is the plan approved and documented, with grant letters showing the grant date, exercise price and vesting schedule?

  • Do you have a market price or valuation at grant, and a Rule 3(8) valuation at each exercise?

  • Is there an option-level register showing vested, exercised, lapsed and forfeited options by year?

  • Has the Ind AS 102 or Guidance Note charge been added back and the Biocon-basis deduction worked separately?

  • Has the exercise-year true-up been claimed, and lapsed options reversed?

  • Was TDS deducted on the perquisite, or deferred correctly for an eligible start-up?

  • For RSU recharges, is the payment benchmarked and reported in Form 3CEB?

Common mistakes

  • Claiming the full grant-date discount in the year of grant instead of over vesting

  • Forgetting the exercise-year true-up, which is often the largest single deduction

  • Not reversing the discount on options that lapse unexercised

  • Treating a loan to an ESOP trust as an expense; a loan is not expenditure

  • Using one valuation for the employees' perquisite and a different one for the company's true-up

  • Accepting a disallowance at assessment because a Supreme Court appeal was pending, without citing the jurisdictional High Court

Practitioner insights

  • Keep the employer's deduction and the employees' perquisite on the same valuation file. Matching figures make the claim much easier to defend.

  • If an assessment disallows the claim, the first appeal grounds should cite the jurisdictional High Court and the assessee's own earlier years, where the deduction was allowed.

  • A deduction missed in the return should go into a revised return while time allows. An updated return cannot be used to reduce income, and a fresh claim at the appeal stage is harder to sustain.

  • For start-ups with losses, the deduction still matters: it increases the carried-forward business loss.

For how a disallowance moves through appeal, see the stage-by-stage guide to income tax notices and appeals.

Valuation-heavy files can also use the free M&A Deal-Shield toolkit.

Old and new section numbers

Point

1961 Act

2025 Act

General deduction for business expenditure

Section 37(1)

Section 34(1)

ESOP perquisite for the employee

Section 17(2)(vi)

Section 17(1)(d)

TDS on salary; start-up deferral

Section 192(1), 192(1C)

Section 392(1), 392(3)

Eligible start-up

Section 80-IAC

Section 140

Concessional company tax rate

Section 115BAA

Section 200

Transfer pricing accountant's report

Section 92E, Form 3CEB

Section 172

Perquisite valuation of shares

Rule 3(8), 1962 Rules

Rule 15(6), 2026 Rules

Frequently asked questions

Is ESOP expense deductible for the employer company in India?

Yes, on the settled High Court view. The Karnataka High Court in CIT v. Biocon Ltd. (2020), the Madras High Court in PVP Ventures (2012) and the Delhi High Court in Lemon Tree Hotels held that the discount on ESOPs is employee cost deductible under section 37(1) of the 1961 Act, now section 34(1) of the Income-tax Act, 2025.

When can the company claim the ESOP deduction?

Over the vesting period, for the options that vest in each year, measured with the market price at the date of grant. The figure is then adjusted in the year of exercise, and reversed for options that lapse.

What happens to the deduction if the share price rises before exercise?

The Biocon Special Bench held that the provisional deduction is trued up at exercise. If the market price at exercise is higher than at grant, the company claims the difference as an additional deduction that year; if lower, the excess is reversed.

Is the deduction the same as the Ind AS 102 charge in the books?

Not necessarily. Ind AS 102 uses a grant-date fair value from an option-pricing model and does not reverse the charge for vested options that later lapse. The tax deduction follows the discount approach accepted by the courts, so the two need to be reconciled in the computation.

Can an Indian subsidiary deduct RSU costs recharged by its foreign parent?

Where the subsidiary actually pays the parent for shares delivered to its employees under an agreement, the Mumbai Tribunal has allowed the payment as employee cost. The recharge is an international transaction, so it must be at arm's length and reported in the transfer pricing accountant's report (Form 3CEB under section 92E, now section 172).

Does the start-up ESOP tax deferral change the employer's deduction?

No. The deferral under section 192(1C) of the 1961 Act, now section 392(3) of the 2025 Act, only postpones when the employer deducts or pays tax on the employee's perquisite. It does not change how or when the company claims its own deduction.

Has the Supreme Court settled the ESOP deduction issue?

The Revenue's appeal against the Delhi High Court ruling in Lemon Tree Hotels was admitted in 2019. A June 2026 report states that the Supreme Court has since dismissed it, but we could not verify the order itself, so rely on the High Court rulings and check the current position before citing it.

Related reading

Sources

Income-tax Act, 1961: sections 17(2)(vi), 37(1), 80-IAC, 92E, 115BAA, 192(1C); Income-tax Act, 2025: sections 17(1)(d), 34(1), 140, 172, 200, 289(3), 392(3); Income-tax Rules, 1962, Rule 3(8). Biocon Ltd. v. DCIT (2013) 35 taxmann.com 335 (Bang.) (SB); CIT v. Biocon Ltd. (2021) 430 ITR 151 (Karn.), ITA 653/2013 dated 11.11.2020; CIT v. PVP Ventures Ltd. (2012) 23 taxmann.com 286 (Mad.); CIT v. Lemon Tree Hotels Ltd., ITA 107/2015 (Delhi HC, 18.08.2015); PCIT v. Lemon Tree Hotels (P.) Ltd. (2019) 104 taxmann.com 26 (Delhi); DCIT v. Kotak Mahindra Bank Ltd. (Mumbai ITAT, 20.12.2017); Goldman Sachs (India) Securities Pvt. Ltd. (Mumbai ITAT); TSI Yatra Pvt. Ltd. v. DCIT (Delhi ITAT, AY 2018-19). Figures are illustrative. Educational content only, reflecting the law as of 3 November 2026; check the current law for your facts.

Guides and toolkits

Practice guides at ₹299 each, or ₹699 for all four.

This is an educational publication for professionals. It is not an offer of professional services.

Comments

Rated 0 out of 5 stars.
No ratings yet

Add a rating
bottom of page